Optimi Health is trading 6.67% down at $2.10, with no clear company-specific catalyst identified for the November 3 decline.

  • The latest identified company releases were dated October 26 and October 20.
  • Biotech was rising while the broad market was mixed; neither clearly explains the drop.
  • The decline follows several consecutive lower closes, but the specific catalyst remains unclear.